ORGANIC
LETTERS
2010
Vol. 12, No. 11
2524-2527
Nucleophilic Substitution of Oxazino-/
Oxazolino-/Benzoxazin [3,2-b]indazoles:
An Effective Route to 1H-Indazolones
Michael B. Donald,† Wayne E. Conrad,† James S. Oakdale,† Jeffrey D. Butler,†
Makhluf J. Haddadin,*,‡ and Mark J. Kurth*,†
Department of Chemistry, UniVersity of California, One Shields AVenue, DaVis,
California 95616, and Department of Chemistry, American UniVersity of Beirut,
Beirut, Lebanon
haddadin@aub.edu.lb; mjkurth@ucdaVis.edu
Received March 31, 2010
ABSTRACT
A variety of nucleophiles, thiolates, alkoxides, amines, iodide, and cyanide, react with oxazino-, oxazolino-, and benzoxazin[3,2-b]indazoles
under microwave conditions to yield a diverse set of 2-substituted 1H-indazolones. The synthetic utility of these indazoles is further demonstrated
by ANRORC (addition of the nucleophile, ring-opening, and ring closure) reactions to yield isomeric pyrazoloindazolones by a process wherein
iodide acts first as a nucleophile and subsequently as a leaving group.
The indazole ring and its derivatives have been reported to
exhibit analgesic,1 antitumor,2 anticancer,3 anti-inflamma-
tory,4 and antifertility activity.5 Of the two indazole isomers,
2H-indazoles are much less explored than 1H-indazoles.6 As
a continuation of our interest in the chemistry of 2H-
indazoles and the related 1H-indazolones,7 we set out to
synthesize a series of 1H-indazolone derivatives as part of
our commitment to the National Institute of General Medical
Sciences (NIGMS) for the creation of pilot-scale libraries.
We recently reported that treatment of 2-(2-nitrobenzy-
lamino)propan-1-ol (1b) with KOH in 10% aqueous i-PrOH
results in a one-pot bis-heterocyclization to oxazolino[3,2-
b]indazole 2b.8 In contrast, treatment of 2-(2-nitrobenzy-
lamino)ethanol (1a) with KOH in 70% aqueous MeOH
produces 2-(2-methoxyethyl)-1H-indazol-3(2H)-one (3a). We
subsequently discovered that treating indazole 2b with
MeOH/KOH causes it to undergo “dealkylative” ring-
opening to give 2-(1-methoxypropan-2-yl)-1H-indazol-3(2H)-
one (3b), suggesting that 1a delivered 3a via the intermediacy
of indazole 2a (Scheme 1).
† University of California.
‡ American University of Beirut.
(1) Fletcher, S. R.; Mclver, E.; Lewis, S.; Burkamp, F.; Leech, C.;
Mason, G.; Boyce, S.; Morrison, D.; Richards, G.; Sutton, K.; Jones, A. B.
Bioorg. Med. Chem. Lett. 2006, 16, 2872.
(2) Wang, H.; Han, H.; Von Hoff, D. D. Cancer Res. 2006, 66, 9722.
(3) Kawanishi, N.; Sugimoto, T.; Shibata, J.; Nakamura, K.; Masutani,
K.; Ikuta, M.; Hirai, H. Bioorg. Med. Chem. Lett. 2006, 16, 5122.
(4) Abouzid, K. A. M.; El-Abhar, H. S. Arch. Pharmacal Res. 2003,
26, 1.
(5) (a) Silvestrini, B.; Cheng, C. Y. US Patent Appl. 99-304042, 1999.
(b) Cerecetto, H.; Gerpe, A.; Gonzalez, M.; Aran, V. J.; de Ocariz, C. O.
Mini-ReV. Med. Chem. 2005, 5, 869.
Herein, we report a study of indazole-based nucleophilic
ring-opening reactions on substrates 2c, 5, and 6. Indazole
(6) (a) Halland, N.; Nazare´, M.; R’kyek, O.; Alonso, J.; Urmann, M.;
Lindenschmidt, A. Angew. Chem., Int. Ed. 2009, 48, 6879. (b) Vin˜a, D.;
del Olmo, E.; Lopez-Pe´rez, J. L.; San Feliciano, A. Org. Lett. 2007, 9,
525. (c) Stadlbauer, W.; Camp, N. In Science of Synthesis: Houben-Weyl
Methods of Molecular Transformations; Bellus, D., Ley, S. V., Noyori, R.,
Regitz, M., Schaumann, E., Shinkai, E., Thomas, E. J., Trost, B. M., Reider,
P. J., Eds.; Thieme: Stuggart, 2002; Vol. 12, p 227.
(7) (a) Dou, G.; Shi, D. J. Comb. Chem. 2009, 11, 1073. (b) Tanimori,
S.; Ozaki, Y.; Iesaki, Y.; Kirihata, M. Synlett 2008, 19, 1973.
(8) Oakdale, J. S.; Solano, D. M.; Fettinger, J. C.; Haddadin, M. J.;
Kurth, M. J. Org. Lett. 2009, 11, 2760.
10.1021/ol100751n 2010 American Chemical Society
Published on Web 05/03/2010